Oxygen Reserve Index-Guided Oxygen Titration During Surgery in the Beach Chair Position (ORI-BCP)

February 9, 2026 updated by: Çağla Sancak, Fatih Sultan Mehmet Training and Research Hospital

The Utility of Oxygen Reserve Index Guidance in Inspiratory Oxygen Titration for Patients Undergoing Surgery in the Beach Chair Position: A Prospective Comparative Study

This study aims to evaluate whether guidance by the Oxygen Reserve Index (ORi) improves inspiratory oxygen fraction (FiO₂) titration compared with conventional pulse oximetry (SpO₂)-guided oxygen administration in adult patients undergoing surgery in the beach chair position.

Oxygen therapy is routinely used during general anesthesia to prevent hypoxemia; however, excessive oxygen administration may result in hyperoxia, which has been associated with adverse cardiovascular and pulmonary effects. Standard pulse oximetry may not adequately detect hyperoxia when oxygen saturation values are high.

In this prospective comparative study, patients will receive oxygen titration guided either by SpO₂ alone or by combined ORi and SpO₂ monitoring. The primary outcome is the incidence of intraoperative hyperoxemia, assessed by arterial blood gas analysis. Secondary outcomes include intraoperative oxygenation parameters and hemodynamic variables.

Study Overview

Detailed Description

This prospective study will be conducted in adult patients (ASA physical status I-III) undergoing elective orthopedic surgery in the beach chair position under general anesthesia. Following approval by the institutional ethics committee and acquisition of written informed consent, eligible patients will be included in the study.

Standard monitoring will include electrocardiography, noninvasive blood pressure, peripheral oxygen saturation (SpO₂), bispectral index (BIS), perfusion index (PI), pleth variability index (PVI), near-infrared spectroscopy (NIRS), and multiwavelength pulse co-oximetry for Oxygen Reserve Index (ORi) monitoring. Invasive arterial blood pressure monitoring will be established via radial arterial cannulation to allow continuous hemodynamic monitoring and arterial blood gas sampling.

General anesthesia will be induced with intravenous propofol, fentanyl, and rocuronium, followed by orotracheal intubation. Mechanical ventilation will be applied in volume-controlled mode with lung-protective settings. Anesthesia will be maintained using sevoflurane and remifentanil infusion, targeting bispectral index values between 40 and 60.

From anesthesia induction onward, inspiratory oxygen fraction (FiO₂) will be titrated either according to SpO₂ values alone or using combined ORi and SpO₂ guidance. In the ORi-guided group, FiO₂ adjustments will aim to maintain ORi values between 0.2 and 0.5, with reassessment at regular intervals. In the SpO₂-guided group, FiO₂ will be adjusted to maintain SpO₂ values at or above 98%, in accordance with routine clinical practice.

Hemodynamic parameters, oxygenation variables, ORi values, and cerebral oxygenation assessed by NIRS will be recorded at predefined time points during surgery and recovery. Arterial blood gas analysis will be performed to determine PaO₂ and arterial oxygen saturation.

Hyperoxemia will be defined as a PaO₂ value of 100 mmHg or greater and classified as mild or severe. The primary outcome of the study is the incidence of intraoperative severe hyperoxemia. Secondary outcomes include overall oxygenation profiles and intraoperative hemodynamic stability.

The results of this study are expected to provide evidence regarding the utility of ORi-guided oxygen titration in reducing unnecessary hyperoxia during surgery performed in the beach chair position.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Istanbul, Turkey (Türkiye), 34000
        • Istanbul Provincial Health Directorate Fatih Sultan Mehmet Training and Research Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult patients aged 18 to 65 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for elective orthopedic surgery in the beach chair position
  • Body mass index (BMI) <35 kg/m²
  • Ability to provide written informed consent

Exclusion Criteria:

  • Age <18 or ≥65 years
  • Finger deformities preventing the use of Oxygen Reserve Index (ORi) monitoring
  • Severe anemia (hemoglobin <8 g/dL)
  • Pregnancy
  • Refusal or inability to provide informed consent
  • History of stroke or significant vascular pathology
  • Severe cardiac or respiratory disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ORi-Guided FiO₂ Titration
Inspiratory oxygen fraction (FiO₂) will be titrated using combined Oxygen Reserve Index (ORi) and peripheral oxygen saturation (SpO₂) monitoring throughout surgery.
Inspiratory oxygen fraction (FiO₂) will be adjusted throughout surgery using combined Oxygen Reserve Index (ORi) and peripheral oxygen saturation (SpO₂) monitoring. FiO₂ will be titrated to maintain ORi values between 0.2 and 0.5, with reassessment every 2-3 minutes.
Active Comparator: SpO₂-Guided Oxygen Titration
Inspiratory oxygen fraction (FiO₂) will be titrated based on peripheral oxygen saturation (SpO₂) values according to routine clinical practice.
FiO₂ will be adjusted to maintain SpO₂ at or above 98% throughout surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Intraoperative Severe Hyperoxemia
Time Frame: Perioperative/Periprocedural
Severe hyperoxemia will be defined as an arterial partial pressure of oxygen (PaO2) ≥200 mmHg, measured by arterial blood gas analysis at predefined intraoperative time points.
Perioperative/Periprocedural

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Peripheral Oxygen Saturation (SpO2) During Surgery
Time Frame: Perioperative/Periprocedural
Peripheral oxygen saturation (SpO2) measured continuously during surgery using standard pulse oximetry.
Perioperative/Periprocedural
Mean Oxygen Reserve Index (ORi) During Surgery
Time Frame: Perioperative/Periprocedural
Oxygen Reserve Index (ORi) values recorded intraoperatively to evaluate oxygenation status.
Perioperative/Periprocedural
Mean Fraction of Inspired Oxygen (FiO₂) During Surgery
Time Frame: Perioperative/Periprocedural
Mean fraction of inspired oxygen (FiO₂) expressed as percentage (%), averaged over the surgical period.
Perioperative/Periprocedural
Mean Cerebral Oxygen Saturation Measured by Near-Infrared Spectroscopy During Surgery
Time Frame: Intraoperative period (from induction of anesthesia to end of surgery)
Cerebral regional oxygen saturation values measured intraoperatively using near-infrared spectroscopy.
Intraoperative period (from induction of anesthesia to end of surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: cagla sancak, MD, Istanbul Provincial Health Directorate Fatih Sultan Mehmet Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 15, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

January 18, 2026

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 11, 2026

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 9, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ORI-FIO2-BCP-2025
  • 2025/234 (Other Identifier: Sancaktepe Şehit Prof. Dr. İlhan Varank education and research hospital Ethics Committee Approval Number)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Oxygenation

Clinical Trials on ORi-Guided FiO₂ Titration

Subscribe